- Home
- JBHT vs BNTX Comparison
JBHT vs BNTX Comparison
Compare JBHT & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBHT | BNTX |
|---|---|---|
| Founded | 1961 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2B | 24.2B |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | JBHT | BNTX |
|---|---|---|
| Price | $269.27 | $90.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 13 |
| Target Price | ★ $220.80 | $133.46 |
| AVG Volume (30 Days) | 907.4K | ★ 990.3K |
| Earning Date | 04-15-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | ★ 10.07 | N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $7,189,568,000.00 | N/A |
| Revenue This Year | $5.76 | N/A |
| Revenue Next Year | $6.62 | $3.37 |
| P/E Ratio | $183.54 | ★ N/A |
| Revenue Growth | ★ 9.67 | N/A |
| 52 Week Low | $130.13 | $79.81 |
| 52 Week High | $293.54 | $124.00 |
Technical Indicators
Market Signals| Indicator | JBHT | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.43 | 49.17 |
| Support Level | $195.69 | $90.67 |
| Resistance Level | $293.54 | $95.14 |
| Average True Range (ATR) | 9.59 | 2.27 |
| MACD | -3.07 | 0.49 |
| Stochastic Oscillator | 13.54 | 69.32 |
Price Performance
Historical ComparisonAbout JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.